{"timestamp": 1771603134.8919618, "value": {"ticker": "BTAI", "company_name": "BioXcel Therapeutics, Inc.", "short_name": "BioXcel Therapeutics, Inc.", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "country": "United States", "market_cap": 34553800, "float_shares": 19467127, "shares_outstanding": 21869491, "short_ratio": 2.4, "short_percent_of_float": 0.0717, "shares_short": 1527067, "shares_short_prior": 1030339, "insider_percent_held": 0.04208, "institution_percent_held": 0.17489, "total_cash": 36176000, "total_debt": 109286000, "total_revenue": 752000, "revenue_growth": -0.542, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -0.28191, "operating_margins": -143.20409, "debt_to_equity": 0, "current_ratio": 1.175, "book_value": -4.447, "price_to_book": -0.35529572, "operating_cashflow": -58214000, "free_cashflow": -43281248, "price": 1.58, "52w_high": 8.08, "52w_low": 1.17, "avg_volume": 532711, "avg_volume_10d": 346920, "full_time_employees": 37, "audit_risk": 7, "overall_risk": 8}}